Role of Endothelin-1 Receptor Antagonists in Vasoconstriction Mediated by Endothelin and Other Vasoconstrictors in Human Internal Mammary Artery

Annals of Thoracic Surgery

Volumn 84, Issue 5, 2007, Pages 1522-1527

  He, Guo Wei ^a,b,c,d   Liu, Ming Hui ^e   Yang, Qin ^a,b   Furnary, Anthony ^a,b   Yim, Anthony P C ^c  

^a Albert Starr Academic Center   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d CENTRAL HOSPITAL OF WUHAN   (China)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN II; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; POTASSIUM CHLORIDE;

AGED; ARTERY CONSTRICTION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DRUG ACTIVITY; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY;

AGED; ENDOTHELIN-1; HUMANS; MAMMARY ARTERIES; MIDDLE AGED; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 35348842782     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.05.064     Document Type: Article

References (24)

1. Inoue A., Yanagisawa M., Kimura S., et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad U S A 86 (1989) 2863-2867
2. Sakurai T., Yanagisawa M., and Masaki T. Molecular characterization of the endothelin receptors. Trends Pharmacol Sci 13 (1992) 103-108
3. Molenaar P., O'Reilly G., Sharkey A., et al. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circulation 72 (1993) 526-538
4. Ogawa Y., Nakao K., Arai H., et al. Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Commun 178 (1991) 248-255
5. Simonson M.S., and Dunn M.J. Cellular signing by peptides of the endothelin gene family. FASEB J 4 (1990) 2989-3000
6. Kiowski W., Linder L., Stoschitzky K., et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenous administered endothelin-1 in clinically healthy smokers. Circulation 90 (1994) 27-34
7. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., and Burnett Jr. J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325 (1991) 997-1001
8. Wei C.M., Lerman A., Rodeheffer R.J., et al. Endothelin in human congestive heart failure. Circulation 89 (1994) 1580-1586
9. Kyriakides Z.S., Kremastinos D.T., Bofilis E., Tousoulis D., Antoniadis A., and Webb D.J. Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary angiography. Heart 84 (2000) 176-182
10. Downing S.W., and Edmunds L.H. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 54 (1992) 1236-1243
11. He G.W., Yang C.Q., and Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg 59 (1995) 676-683
12. Seo B., Oemar B.S., Siebenmann R., von Segesser L., and Luscher T.F. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89 (1994) 1203-1208
13. Spratt J.C.S., Goddard J., Patel N., Strachan F.E., Rankin A.J., and Webb D.J. Systemic ETA receptor antagonist with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 134 (2001) 648-654
14. Halcox J.P.J., Nour K.R.A., Zalos G., and Quyyumi A.A. Coronary vasodilation and improvement in endothelial dysfunction with endothlin ETA receptor blockade. Circ Res 89 (2001) 969-976
15. Verma S., Lovren F., Dumont A.S., et al. Endothelin receptor blockade improves endothelial function in human internal mammary arteries. Cardiovasc Res 49 (2001) 146-151
16. He G.W., Yang C.Q., Mack M.J., Acuff T.E., Ryan W.H., and Starr A. Interaction between endothelin and vasodilators in the human internal mammary artery. Br J Clin Pharmacol 38 (1994) 505-512
17. He G.W., and Yang C.Q. Comparison of nitroprusside and nitroglycerin in inhibition of angiotensin II and other vasoconstrictor-mediated contraction in human coronary bypass conduits. Br J Clin Pharmacol 44 (1997) 361-367
18. Liu M.H., Jin H.K., Floten H.S., Ren Z., Yim A.P.C., and He G.W. Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery. Ann Thorac Surg 73 (2002) 819-824
19. Faure S., Javellaud J., Achard J.M., and Oudart N. Vasoconstrictive effect of angiotensin IV in isolated rat basilar artery independent of AT1 and AT2 receptors. J Vasc Res 43 (2006) 19-26
20. He G.W., and Yang C.Q. Radial artery has higher receptor-mediated contractility but similar endothelial function compared with mammary artery. Ann Thorac Surg 63 (1997) 1346-1352
21. Hynynen M., Saijonmaa O., Tikkanen I., Heinonen J., and Fyhrquist F. Increased plasma endothelin immunoreactivity during cardiopulmonary bypass: a preliminary observation. J Thorac Cardiovasc Surg 103 (1992) 1024-1025
22. He G.W., and Yang C.Q. Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro. Br J Clin Pharmacol 48 (1999) 99-104
23. Alberola Aguilar A.M., Revert F., et al. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion. Gen Pharmacol 35 (2000) 143-147
24. Holm P., Liska J., and Franco-Cereceda A. The endothelin ETB receptor antagonist BQ-788 reduces the pulmonary vasodilator effect of endothelin-1 during acute hypoxia in pigs. Eur J Pharmacol 323 (1997) 83-87